Shoulder Pain Pumps

Kane Legal is currently reviewing chondrolysis cases related to shoulder pain pump devices.

If you or a loved one has sustained cartilage injuries as a result of a shoulder pain pump, please call Kane Legal for a free consultation.

Shoulder pain pumps have been used to manage pain after arthroscopic shoulder surgery. They have grown to be popular since they reduce the amount of breakthrough pain (pain experienced even while on pain medications) while reducing the side effects of pain medications.

However, studies now indicate that shoulder pain pumps should be avoided post arthroscopic surgery because of a link between shoulder pain pumps and the development of post arthroscopic glenohumeral chondrolysis (PAGCL). PAGCL is a condition where the cartilage of a joint is rapidly destroyed resulting in limited range of motion and extreme pain. In 2008, a warning by the FDA was issued stating that “almost all of the reported cases of chondrolysis [occurred 97%] following shoulder surgeries.  Despite the warning, manufacturers like I-Flow (owned by Kimberly-Clark) and drug companies like AstraZeneca (which manufactured the anesthetic used in the pumps) kept pain pumps on the market.

If you are suffering from PAGCL, you may find that you are unable to perform basic day to day activities like tying shoelaces or picking up objects. If you or a loved one has or had an implanted shoulder pain pump and is injured, you may be entitled to financial compensation. For a free legal consultation, please contact our pharmacist attorney at Kane Legal.